| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,403 | 2,308 | 1,540 | | Cost of Revenue | 1,073 | 968 | 781 | | | Gross Profit | 1,330 | 1,339 | 758 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,441 | 2,070 | 2,302 | | Non Recurring | (358) |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 247 | (730) | (1,544) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4 | 7 | 9 | | Earnings Before Interest And Taxes | 250 | (723) | (1,535) | | Interest Expense | 33 | 36 | 24 | | Income Before Tax | 217 | (760) | (1,559) | | Income Tax Expense | 68 |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 150 | (760) | (1,559) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 150 | (760) | (1,559) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $150 | ($760) | ($1,559) |
|
0.67% Nasdaq 0.00%
Income Statement
